Memorial Sloan-Kettering Cancer Center Insider Profile
4 Followers
Memorial Sloan-Kettering Cancer Center, Ten Percent Owner at Actinium Pharmaceuticals, holds 5.70M shares in Actinium Pharmaceuticals (Ticker: ATNM). Most recently, Memorial Sloan-Kettering Cancer Center Sold $192,927 shares of Actinium Pharmaceuticals on Sep 01, 2016 for an estimated value of 352.36K.
Memorial Sloan-Kettering Cancer Center insider profile FAQ
What is the percentage of profitable transactions made by Memorial Sloan-Kettering Cancer Center?
The percentage of profitable transactions made by Memorial Sloan-Kettering Cancer Center is 100%.
What is the average return per transaction made by Memorial Sloan-Kettering Cancer Center?
The average return per transaction made by Memorial Sloan-Kettering Cancer Center is 37.80%.
What stocks does Memorial Sloan-Kettering Cancer Center hold?
Memorial Sloan-Kettering Cancer Center holds: ATNM stocks.
What was Memorial Sloan-Kettering Cancer Center’s latest transaction?
Memorial Sloan-Kettering Cancer Center latest transaction was an Informative Sell of $352.36K.
What was Memorial Sloan-Kettering Cancer Center's most profitable transaction?
Memorial Sloan-Kettering Cancer Center’s most profitable transaction was an Informative Sell of ATNM stock on August 30, 2016. The return on the trade was 64.60%.
What is Memorial Sloan-Kettering Cancer Center's role in Actinium Pharmaceuticals?
Memorial Sloan-Kettering Cancer Center's role in Actinium Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.